Future DES Purchasing Strategy: A “Price Is Right” Approach?
Pricing strategies and ease of use factors likely will overshadow clinical efficacy as Boston Scientific and Johnson & Johnson joust for dominance in the U.S. drug-eluting stent market
Pricing strategies and ease of use factors likely will overshadow clinical efficacy as Boston Scientific and Johnson & Johnson joust for dominance in the U.S. drug-eluting stent market